English
简体中文
Total: £ 56.28
Published Date: 2026-03-18 | Pages: 112 | Tables: 113 | Medical Care
The global Cardiac Disease Stem Cell Therapy market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The North American market for Cardiac Disease Stem Cell Therapy is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Cardiac Disease Stem Cell Therapy is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Cardiac Disease Stem Cell Therapy in Preclinical is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Cardiac Disease Stem Cell Therapy include Pharmicell, Gencell, BlueRock Therapeutics, Cellino Biotech, Mesoblast, BioCardia, Cedars-Sinai, Stem Cells Transplant Institute, CCTRN, Help Therapeutics Co., Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Cardiac Disease Stem Cell Therapy market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cardiac Disease Stem Cell Therapy. The Cardiac Disease Stem Cell Therapy market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Cardiac Disease Stem Cell Therapy market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Cardiac Disease Stem Cell Therapy manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Pharmicell
Gencell
BlueRock Therapeutics
Cellino Biotech
Mesoblast
BioCardia
Cedars-Sinai
Stem Cells Transplant Institute
CCTRN
Help Therapeutics Co., Ltd.
Beijing Cellapy biotechnology Co., LTD
CardioCell
Heartseed
EmCell
Segment by Type
Autologous
Allogeneic
Segment by Application
Preclinical
Clinical Phase 1,2
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Cardiac Disease Stem Cell Therapy companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cardiac Disease Stem Cell Therapy Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Autologous
1.2.3 Allogeneic
1.3 Market by Application
1.3.1 Global Cardiac Disease Stem Cell Therapy Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Preclinical
1.3.3 Clinical Phase 1,2
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cardiac Disease Stem Cell Therapy Market Perspective (2021–2032)
2.2 Global Cardiac Disease Stem Cell Therapy Growth Trends by Region
2.2.1 Global Cardiac Disease Stem Cell Therapy Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Cardiac Disease Stem Cell Therapy Historic Market Size by Region (2021–2026)
2.2.3 Cardiac Disease Stem Cell Therapy Forecasted Market Size by Region (2027–2032)
2.3 Cardiac Disease Stem Cell Therapy Market Dynamics
2.3.1 Cardiac Disease Stem Cell Therapy Industry Trends
2.3.2 Cardiac Disease Stem Cell Therapy Market Drivers
2.3.3 Cardiac Disease Stem Cell Therapy Market Challenges
2.3.4 Cardiac Disease Stem Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cardiac Disease Stem Cell Therapy Players by Revenue
3.1.1 Global Top Cardiac Disease Stem Cell Therapy Players by Revenue (2021–2026)
3.1.2 Global Cardiac Disease Stem Cell Therapy Revenue Market Share by Players (2021–2026)
3.2 Global Top Cardiac Disease Stem Cell Therapy Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Cardiac Disease Stem Cell Therapy Revenue
3.4 Global Cardiac Disease Stem Cell Therapy Market Concentration Ratio
3.4.1 Global Cardiac Disease Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cardiac Disease Stem Cell Therapy Revenue in 2025
3.5 Global Key Players of Cardiac Disease Stem Cell Therapy Head Offices and Areas Served
3.6 Global Key Players of Cardiac Disease Stem Cell Therapy, Products and Applications
3.7 Global Key Players of Cardiac Disease Stem Cell Therapy, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Cardiac Disease Stem Cell Therapy Breakdown Data by Type
4.1 Global Cardiac Disease Stem Cell Therapy Historic Market Size by Type (2021–2026)
4.2 Global Cardiac Disease Stem Cell Therapy Forecasted Market Size by Type (2027–2032)
5 Cardiac Disease Stem Cell Therapy Breakdown Data by Application
5.1 Global Cardiac Disease Stem Cell Therapy Historic Market Size by Application (2021–2026)
5.2 Global Cardiac Disease Stem Cell Therapy Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Cardiac Disease Stem Cell Therapy Market Size (2021–2032)
6.2 North America Cardiac Disease Stem Cell Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Cardiac Disease Stem Cell Therapy Market Size by Country (2021–2026)
6.4 North America Cardiac Disease Stem Cell Therapy Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cardiac Disease Stem Cell Therapy Market Size (2021–2032)
7.2 Europe Cardiac Disease Stem Cell Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Cardiac Disease Stem Cell Therapy Market Size by Country (2021–2026)
7.4 Europe Cardiac Disease Stem Cell Therapy Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Cardiac Disease Stem Cell Therapy Market Size (2021–2032)
8.2 Asia-Pacific Cardiac Disease Stem Cell Therapy Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Cardiac Disease Stem Cell Therapy Market Size by Region (2021–2026)
8.4 Asia-Pacific Cardiac Disease Stem Cell Therapy Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Cardiac Disease Stem Cell Therapy Market Size (2021–2032)
9.2 Latin America Cardiac Disease Stem Cell Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Cardiac Disease Stem Cell Therapy Market Size by Country (2021–2026)
9.4 Latin America Cardiac Disease Stem Cell Therapy Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cardiac Disease Stem Cell Therapy Market Size (2021–2032)
10.2 Middle East & Africa Cardiac Disease Stem Cell Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Cardiac Disease Stem Cell Therapy Market Size by Country (2021–2026)
10.4 Middle East & Africa Cardiac Disease Stem Cell Therapy Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pharmicell
11.1.1 Pharmicell Company Details
11.1.2 Pharmicell Business Overview
11.1.3 Pharmicell Cardiac Disease Stem Cell Therapy Introduction
11.1.4 Pharmicell Revenue in Cardiac Disease Stem Cell Therapy Business (2021–2026)
11.1.5 Pharmicell Recent Development
11.2 Gencell
11.2.1 Gencell Company Details
11.2.2 Gencell Business Overview
11.2.3 Gencell Cardiac Disease Stem Cell Therapy Introduction
11.2.4 Gencell Revenue in Cardiac Disease Stem Cell Therapy Business (2021–2026)
11.2.5 Gencell Recent Development
11.3 BlueRock Therapeutics
11.3.1 BlueRock Therapeutics Company Details
11.3.2 BlueRock Therapeutics Business Overview
11.3.3 BlueRock Therapeutics Cardiac Disease Stem Cell Therapy Introduction
11.3.4 BlueRock Therapeutics Revenue in Cardiac Disease Stem Cell Therapy Business (2021–2026)
11.3.5 BlueRock Therapeutics Recent Development
11.4 Cellino Biotech
11.4.1 Cellino Biotech Company Details
11.4.2 Cellino Biotech Business Overview
11.4.3 Cellino Biotech Cardiac Disease Stem Cell Therapy Introduction
11.4.4 Cellino Biotech Revenue in Cardiac Disease Stem Cell Therapy Business (2021–2026)
11.4.5 Cellino Biotech Recent Development
11.5 Mesoblast
11.5.1 Mesoblast Company Details
11.5.2 Mesoblast Business Overview
11.5.3 Mesoblast Cardiac Disease Stem Cell Therapy Introduction
11.5.4 Mesoblast Revenue in Cardiac Disease Stem Cell Therapy Business (2021–2026)
11.5.5 Mesoblast Recent Development
11.6 BioCardia
11.6.1 BioCardia Company Details
11.6.2 BioCardia Business Overview
11.6.3 BioCardia Cardiac Disease Stem Cell Therapy Introduction
11.6.4 BioCardia Revenue in Cardiac Disease Stem Cell Therapy Business (2021–2026)
11.6.5 BioCardia Recent Development
11.7 Cedars-Sinai
11.7.1 Cedars-Sinai Company Details
11.7.2 Cedars-Sinai Business Overview
11.7.3 Cedars-Sinai Cardiac Disease Stem Cell Therapy Introduction
11.7.4 Cedars-Sinai Revenue in Cardiac Disease Stem Cell Therapy Business (2021–2026)
11.7.5 Cedars-Sinai Recent Development
11.8 Stem Cells Transplant Institute
11.8.1 Stem Cells Transplant Institute Company Details
11.8.2 Stem Cells Transplant Institute Business Overview
11.8.3 Stem Cells Transplant Institute Cardiac Disease Stem Cell Therapy Introduction
11.8.4 Stem Cells Transplant Institute Revenue in Cardiac Disease Stem Cell Therapy Business (2021–2026)
11.8.5 Stem Cells Transplant Institute Recent Development
11.9 CCTRN
11.9.1 CCTRN Company Details
11.9.2 CCTRN Business Overview
11.9.3 CCTRN Cardiac Disease Stem Cell Therapy Introduction
11.9.4 CCTRN Revenue in Cardiac Disease Stem Cell Therapy Business (2021–2026)
11.9.5 CCTRN Recent Development
11.10 Help Therapeutics Co., Ltd.
11.10.1 Help Therapeutics Co., Ltd. Company Details
11.10.2 Help Therapeutics Co., Ltd. Business Overview
11.10.3 Help Therapeutics Co., Ltd. Cardiac Disease Stem Cell Therapy Introduction
11.10.4 Help Therapeutics Co., Ltd. Revenue in Cardiac Disease Stem Cell Therapy Business (2021–2026)
11.10.5 Help Therapeutics Co., Ltd. Recent Development
11.11 Beijing Cellapy biotechnology Co., LTD
11.11.1 Beijing Cellapy biotechnology Co., LTD Company Details
11.11.2 Beijing Cellapy biotechnology Co., LTD Business Overview
11.11.3 Beijing Cellapy biotechnology Co., LTD Cardiac Disease Stem Cell Therapy Introduction
11.11.4 Beijing Cellapy biotechnology Co., LTD Revenue in Cardiac Disease Stem Cell Therapy Business (2021–2026)
11.11.5 Beijing Cellapy biotechnology Co., LTD Recent Development
11.12 CardioCell
11.12.1 CardioCell Company Details
11.12.2 CardioCell Business Overview
11.12.3 CardioCell Cardiac Disease Stem Cell Therapy Introduction
11.12.4 CardioCell Revenue in Cardiac Disease Stem Cell Therapy Business (2021–2026)
11.12.5 CardioCell Recent Development
11.13 Heartseed
11.13.1 Heartseed Company Details
11.13.2 Heartseed Business Overview
11.13.3 Heartseed Cardiac Disease Stem Cell Therapy Introduction
11.13.4 Heartseed Revenue in Cardiac Disease Stem Cell Therapy Business (2021–2026)
11.13.5 Heartseed Recent Development
11.14 EmCell
11.14.1 EmCell Company Details
11.14.2 EmCell Business Overview
11.14.3 EmCell Cardiac Disease Stem Cell Therapy Introduction
11.14.4 EmCell Revenue in Cardiac Disease Stem Cell Therapy Business (2021–2026)
11.14.5 EmCell Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Cardiac Disease Stem Cell Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Autologous
Table 3. Key Players of Allogeneic
Table 4. Global Cardiac Disease Stem Cell Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Cardiac Disease Stem Cell Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Cardiac Disease Stem Cell Therapy Market Size by Region (US$ Million), 2021–2026
Table 7. Global Cardiac Disease Stem Cell Therapy Market Share by Region (2021–2026)
Table 8. Global Cardiac Disease Stem Cell Therapy Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Cardiac Disease Stem Cell Therapy Market Share by Region (2027–2032)
Table 10. Cardiac Disease Stem Cell Therapy Market Trends
Table 11. Cardiac Disease Stem Cell Therapy Market Drivers
Table 12. Cardiac Disease Stem Cell Therapy Market Challenges
Table 13. Cardiac Disease Stem Cell Therapy Market Restraints
Table 14. Global Cardiac Disease Stem Cell Therapy Revenue by Players (US$ Million), 2021–2026
Table 15. Global Cardiac Disease Stem Cell Therapy Market Share by Players (2021–2026)
Table 16. Global Top Cardiac Disease Stem Cell Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on Cardiac Disease Stem Cell Therapy Revenue, 2025
Table 17. Ranking of Global Top Cardiac Disease Stem Cell Therapy Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Cardiac Disease Stem Cell Therapy Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Cardiac Disease Stem Cell Therapy, Headquarters and Area Served
Table 20. Global Key Players of Cardiac Disease Stem Cell Therapy, Products and Applications
Table 21. Global Key Players of Cardiac Disease Stem Cell Therapy, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Cardiac Disease Stem Cell Therapy Market Size by Type (US$ Million), 2021–2026
Table 24. Global Cardiac Disease Stem Cell Therapy Revenue Market Share by Type (2021–2026)
Table 25. Global Cardiac Disease Stem Cell Therapy Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Cardiac Disease Stem Cell Therapy Revenue Market Share by Type (2027–2032)
Table 27. Global Cardiac Disease Stem Cell Therapy Market Size by Application (US$ Million), 2021–2026
Table 28. Global Cardiac Disease Stem Cell Therapy Revenue Market Share by Application (2021–2026)
Table 29. Global Cardiac Disease Stem Cell Therapy Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Cardiac Disease Stem Cell Therapy Revenue Market Share by Application (2027–2032)
Table 31. North America Cardiac Disease Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Cardiac Disease Stem Cell Therapy Market Size by Country (US$ Million), 2021–2026
Table 33. North America Cardiac Disease Stem Cell Therapy Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Cardiac Disease Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Cardiac Disease Stem Cell Therapy Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Cardiac Disease Stem Cell Therapy Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Cardiac Disease Stem Cell Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Cardiac Disease Stem Cell Therapy Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Cardiac Disease Stem Cell Therapy Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Cardiac Disease Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Cardiac Disease Stem Cell Therapy Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Cardiac Disease Stem Cell Therapy Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Cardiac Disease Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Cardiac Disease Stem Cell Therapy Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Cardiac Disease Stem Cell Therapy Market Size by Country (US$ Million), 2027–2032
Table 46. Pharmicell Company Details
Table 47. Pharmicell Business Overview
Table 48. Pharmicell Cardiac Disease Stem Cell Therapy Product
Table 49. Pharmicell Revenue in Cardiac Disease Stem Cell Therapy Business (US$ Million), 2021–2026
Table 50. Pharmicell Recent Development
Table 51. Gencell Company Details
Table 52. Gencell Business Overview
Table 53. Gencell Cardiac Disease Stem Cell Therapy Product
Table 54. Gencell Revenue in Cardiac Disease Stem Cell Therapy Business (US$ Million), 2021–2026
Table 55. Gencell Recent Development
Table 56. BlueRock Therapeutics Company Details
Table 57. BlueRock Therapeutics Business Overview
Table 58. BlueRock Therapeutics Cardiac Disease Stem Cell Therapy Product
Table 59. BlueRock Therapeutics Revenue in Cardiac Disease Stem Cell Therapy Business (US$ Million), 2021–2026
Table 60. BlueRock Therapeutics Recent Development
Table 61. Cellino Biotech Company Details
Table 62. Cellino Biotech Business Overview
Table 63. Cellino Biotech Cardiac Disease Stem Cell Therapy Product
Table 64. Cellino Biotech Revenue in Cardiac Disease Stem Cell Therapy Business (US$ Million), 2021–2026
Table 65. Cellino Biotech Recent Development
Table 66. Mesoblast Company Details
Table 67. Mesoblast Business Overview
Table 68. Mesoblast Cardiac Disease Stem Cell Therapy Product
Table 69. Mesoblast Revenue in Cardiac Disease Stem Cell Therapy Business (US$ Million), 2021–2026
Table 70. Mesoblast Recent Development
Table 71. BioCardia Company Details
Table 72. BioCardia Business Overview
Table 73. BioCardia Cardiac Disease Stem Cell Therapy Product
Table 74. BioCardia Revenue in Cardiac Disease Stem Cell Therapy Business (US$ Million), 2021–2026
Table 75. BioCardia Recent Development
Table 76. Cedars-Sinai Company Details
Table 77. Cedars-Sinai Business Overview
Table 78. Cedars-Sinai Cardiac Disease Stem Cell Therapy Product
Table 79. Cedars-Sinai Revenue in Cardiac Disease Stem Cell Therapy Business (US$ Million), 2021–2026
Table 80. Cedars-Sinai Recent Development
Table 81. Stem Cells Transplant Institute Company Details
Table 82. Stem Cells Transplant Institute Business Overview
Table 83. Stem Cells Transplant Institute Cardiac Disease Stem Cell Therapy Product
Table 84. Stem Cells Transplant Institute Revenue in Cardiac Disease Stem Cell Therapy Business (US$ Million), 2021–2026
Table 85. Stem Cells Transplant Institute Recent Development
Table 86. CCTRN Company Details
Table 87. CCTRN Business Overview
Table 88. CCTRN Cardiac Disease Stem Cell Therapy Product
Table 89. CCTRN Revenue in Cardiac Disease Stem Cell Therapy Business (US$ Million), 2021–2026
Table 90. CCTRN Recent Development
Table 91. Help Therapeutics Co., Ltd. Company Details
Table 92. Help Therapeutics Co., Ltd. Business Overview
Table 93. Help Therapeutics Co., Ltd. Cardiac Disease Stem Cell Therapy Product
Table 94. Help Therapeutics Co., Ltd. Revenue in Cardiac Disease Stem Cell Therapy Business (US$ Million), 2021–2026
Table 95. Help Therapeutics Co., Ltd. Recent Development
Table 96. Beijing Cellapy biotechnology Co., LTD Company Details
Table 97. Beijing Cellapy biotechnology Co., LTD Business Overview
Table 98. Beijing Cellapy biotechnology Co., LTD Cardiac Disease Stem Cell Therapy Product
Table 99. Beijing Cellapy biotechnology Co., LTD Revenue in Cardiac Disease Stem Cell Therapy Business (US$ Million), 2021–2026
Table 100. Beijing Cellapy biotechnology Co., LTD Recent Development
Table 101. CardioCell Company Details
Table 102. CardioCell Business Overview
Table 103. CardioCell Cardiac Disease Stem Cell Therapy Product
Table 104. CardioCell Revenue in Cardiac Disease Stem Cell Therapy Business (US$ Million), 2021–2026
Table 105. CardioCell Recent Development
Table 106. Heartseed Company Details
Table 107. Heartseed Business Overview
Table 108. Heartseed Cardiac Disease Stem Cell Therapy Product
Table 109. Heartseed Revenue in Cardiac Disease Stem Cell Therapy Business (US$ Million), 2021–2026
Table 110. Heartseed Recent Development
Table 111. EmCell Company Details
Table 112. EmCell Business Overview
Table 113. EmCell Cardiac Disease Stem Cell Therapy Product
Table 114. EmCell Revenue in Cardiac Disease Stem Cell Therapy Business (US$ Million), 2021–2026
Table 115. EmCell Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 119. Authors List of This Report
List of Figures
Figure 1. Cardiac Disease Stem Cell Therapy Picture
Figure 2. Global Cardiac Disease Stem Cell Therapy Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Cardiac Disease Stem Cell Therapy Market Share by Type: 2025 vs 2032
Figure 4. Autologous Features
Figure 5. Allogeneic Features
Figure 6. Global Cardiac Disease Stem Cell Therapy Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Cardiac Disease Stem Cell Therapy Market Share by Application: 2025 vs 2032
Figure 8. Preclinical Case Studies
Figure 9. Clinical Phase 1,2 Case Studies
Figure 10. Cardiac Disease Stem Cell Therapy Report Years Considered
Figure 11. Global Cardiac Disease Stem Cell Therapy Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 12. Global Cardiac Disease Stem Cell Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Cardiac Disease Stem Cell Therapy Market Share by Region: 2025 vs 2032
Figure 14. Global Cardiac Disease Stem Cell Therapy Market Share by Players in 2025
Figure 15. Global Cardiac Disease Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 16. The Top 10 and 5 Players Market Share by Cardiac Disease Stem Cell Therapy Revenue in 2025
Figure 17. North America Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 18. North America Cardiac Disease Stem Cell Therapy Market Share by Country (2021–2032)
Figure 19. United States Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. Canada Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Europe Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Cardiac Disease Stem Cell Therapy Market Share by Country (2021–2032)
Figure 23. Germany Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. France Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. U.K. Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Italy Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Russia Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Ireland Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Asia-Pacific Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Cardiac Disease Stem Cell Therapy Market Share by Region (2021–2032)
Figure 31. China Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Japan Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. South Korea Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Southeast Asia Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. India Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Australia & New Zealand Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Latin America Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Cardiac Disease Stem Cell Therapy Market Share by Country (2021–2032)
Figure 39. Mexico Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Brazil Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Middle East & Africa Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Cardiac Disease Stem Cell Therapy Market Share by Country (2021–2032)
Figure 43. Israel Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Saudi Arabia Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. UAE Cardiac Disease Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Pharmicell Revenue Growth Rate in Cardiac Disease Stem Cell Therapy Business (2021–2026)
Figure 47. Gencell Revenue Growth Rate in Cardiac Disease Stem Cell Therapy Business (2021–2026)
Figure 48. BlueRock Therapeutics Revenue Growth Rate in Cardiac Disease Stem Cell Therapy Business (2021–2026)
Figure 49. Cellino Biotech Revenue Growth Rate in Cardiac Disease Stem Cell Therapy Business (2021–2026)
Figure 50. Mesoblast Revenue Growth Rate in Cardiac Disease Stem Cell Therapy Business (2021–2026)
Figure 51. BioCardia Revenue Growth Rate in Cardiac Disease Stem Cell Therapy Business (2021–2026)
Figure 52. Cedars-Sinai Revenue Growth Rate in Cardiac Disease Stem Cell Therapy Business (2021–2026)
Figure 53. Stem Cells Transplant Institute Revenue Growth Rate in Cardiac Disease Stem Cell Therapy Business (2021–2026)
Figure 54. CCTRN Revenue Growth Rate in Cardiac Disease Stem Cell Therapy Business (2021–2026)
Figure 55. Help Therapeutics Co., Ltd. Revenue Growth Rate in Cardiac Disease Stem Cell Therapy Business (2021–2026)
Figure 56. Beijing Cellapy biotechnology Co., LTD Revenue Growth Rate in Cardiac Disease Stem Cell Therapy Business (2021–2026)
Figure 57. CardioCell Revenue Growth Rate in Cardiac Disease Stem Cell Therapy Business (2021–2026)
Figure 58. Heartseed Revenue Growth Rate in Cardiac Disease Stem Cell Therapy Business (2021–2026)
Figure 59. EmCell Revenue Growth Rate in Cardiac Disease Stem Cell Therapy Business (2021–2026)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
